Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT03671486Completed

Colonization with Group B Streptococcus During Pregnancy

Role: collaborator

NCT06121583Completed

Cross-sectional, Non-randomized Observational Study to Assess the Frequency of Reduced Sodium Intake in the Primary Care Setting - LAXAP

Role: lead

NCT04297423Phase 4Completed

Two Low Volume Regimens for Colorectal Cancer Screening Colonoscopy

Role: collaborator

NCT03669094Not ApplicableCompleted

Effect of a New Probiotic Strain in the Reduction of Group B Streptococcus Colonization in Pregnant Women

Role: collaborator

NCT03614117Not ApplicableCompleted

Effect of a New Probiotic Strain on Recurrent Acute Otitis Media in Children (PROMAR)

Role: collaborator

NCT02839824Completed

Evaluation of the Quality of Bowel Cleansing in a Real Clinical Practice Setting

Role: lead

All 6 trials loaded